Literature DB >> 11840330

HER2/Neu: mechanisms of dimerization/oligomerization.

Patrick J Brennan, Toru Kumagai, Alan Berezov, Ramachandran Murali, Mark I Greene.   

Abstract

DOI: 10.1038/sj/onc/1205119

Entities:  

Year:  2002        PMID： 11840330     DOI： 10.1038/sj.onc.1205119

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


  8 in total

1.  Down-regulation of vascular endothelial growth factor expression by anti-Her2/neu single chain antibodies.

Authors:  Foroogh Nejatollahi; Mahdi Asgharpour; Mansooreh Jaberipour
Journal:  Med Oncol       Date:  2011-01-26       Impact factor: 3.064

Review 2.  Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapy.

Authors:  Pravin T P Kaumaya; Kevin Chu Foy
Journal:  Future Oncol       Date:  2012-08       Impact factor: 3.404

3.  Functional Common and Rare ERBB2 Germline Variants Cooperate in Familial and Sporadic Cancer Susceptibility.

Authors:  Riyue Bao; Anita Ng; Mark Sasaki; Myvizhi Esai Selvan; Alyna Katti; Hyesan Lee; Lei Huang; Andrew D Skol; Cinzia Lavarino; Hector Salvador; Robert J Klein; Zeynep H Gümüş; Jaume Mora; Kenan Onel
Journal:  Cancer Prev Res (Phila)       Date:  2021-01-08

Review 4.  ErbB receptors and their growth factor ligands in pediatric intestinal inflammation.

Authors:  Mark R Frey; D Brent Polk
Journal:  Pediatr Res       Date:  2013-11-06       Impact factor: 3.756

5.  Molecular architecture of the ErbB2 extracellular domain homodimer.

Authors:  Shi Hu; Yuna Sun; Yanchun Meng; Xiaoze Wang; Weili Yang; Wenyan Fu; Huaizu Guo; Weizhu Qian; Sheng Hou; Bohua Li; Zihe Rao; Zhiyong Lou; Yajun Guo
Journal:  Oncotarget       Date:  2015-01-30

6.  Therapeutic siRNA for drug-resistant HER2-positive breast cancer.

Authors:  Shenda Gu; Zhi Hu; Worapol Ngamcherdtrakul; David J Castro; Jingga Morry; Moataz M Reda; Joe W Gray; Wassana Yantasee
Journal:  Oncotarget       Date:  2016-03-22

Review 7.  Monoclonal Antibodies against the MET/HGF Receptor and Its Ligand: Multitask Tools with Applications from Basic Research to Therapy.

Authors:  Maria Prat; Francesca Oltolina; Cristina Basilico
Journal:  Biomedicines       Date:  2014-12-03

8.  Local variations of HER2 dimerization in breast cancer cells discovered by correlative fluorescence and liquid electron microscopy.

Authors:  Diana B Peckys; Ulrike Korf; Niels de Jonge
Journal:  Sci Adv       Date:  2015-07-17       Impact factor: 14.136
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.